Ru-Vert

contains 25mg pentylenetetrazole, 12.5mg pheniramine maleate & 50mg nicotinic acid

Also Known As:

3-Pyridinecarboxylic acid, mixt. with N,N-dimethyl-gamma-phenyl-2-pyridinepropanamine (Z)-2-butenedioate (1:1) and 6,7,8,9-tetrahydro-5H-tetrazolo(1,5-a)azepine

Networked: 3 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Pharmaceutical Preparations
- Drug Combinations: 5337
  - Ru-Vert: 3
Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyridines: 88
    - Pheniramine: 68
      - Ru-Vert: 3
    - Nicotinic Acids: 13
      - Ru-Vert: 3
  - Azepines: 11
    - Pentylenetetrazole: 3136
      - Ru-Vert: 3
- Heterocyclic Acids
  - Nicotinic Acids: 13
    - Ru-Vert: 3

Related Diseases

1.	Vertigo (Positional Vertigo) 11/01/1967 - "A double-blind, placebo-controlled study of Ru-Vert in patients with vertigo." 10/01/1966 - "A clinical study of Ru-Vert in the management of vertigo."
2.	Benign Paroxysmal Positional Vertigo 03/01/1975 - "Summary--Ru-Vert, a combination product, containing in each tablet, 25 mg of pentylenetetrazol, 12.5 mg of pheniramine maleate, and 50 mg of nictonic acid, was evaluated in the treatment of seventeen patients with benign paroxysmal positional vertigo. "

Related Drugs and Biologics

1.	Tablets
2.	Pheniramine (Pheniramine Maleate)
3.	Pentylenetetrazole (Metrazol)
4.	Acids